Effects of QUANTUM Probe for Skin Rejuvenation and Subdermal Retraction in Patients Undergoing High-Definition Liposculpture

Launched by TOTAL DEFINER RESEARCH GROUP · Apr 27, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a treatment called the Quantum Probe, which uses a special technology to help tighten and rejuvenate the skin. It’s aimed at patients who are having a High-Definition Liposculpture, a type of body contouring surgery that shapes and sculpts the body. The main goals of the study are to find out if the Quantum Probe can effectively reduce skin laxity, which is when the skin becomes loose and less firm, and whether factors like age and gender affect how well it works.

To participate in this trial, you need to be an adult between 18 and 60 years old and planning to undergo liposuction or liposculpture. You should be generally healthy without serious medical issues. However, if you are pregnant, have certain skin or autoimmune diseases, or have a high body mass index, you won’t be eligible. If you join the study, you can expect to receive the treatment and help researchers learn more about its safety and effectiveness. This information could contribute to better options for skin tightening in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing body contouring procedures (liposuction or liposculpture), either individually or combined with a maximum of two other major aesthetic procedures involving face, breast, or dermolipectomy.
• • Healthy patients without underlying comorbidities (classified as ASA≤II)
• Exclusion Criteria:
• • Pregnant patients, patients planning to get pregnant, or in breastfeeding stage
• • Past medical history of any collagen disease or autoimmune conditions, including lupus, scleroderma, connective tissue disorders, rheumatoid arthritis, or multiple sclerosis.
• • Past medical history of skin disease including active skin infections, dermatitis, or history of keloid formation.
• • Patient with any metal implants or pacemakers
• • BMI ≥ 32 kg/m2.